SOX2 and melanoma: By exploiting an in vitro model of extracellular acidosis, we demonstrated that SOX2 is induced by an acidic microenvironment and, importantly, that SOX2 depletion in acidic melanoma cells reprograms their metabolism to a more glycolytic phenotype, also reducing OxPhos-related genes that characterize acidosis-exposed melanoma cells.